Login

Consolidated balance sheets

In millions of USD, except per-share amounts
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Assets
Current assets:
Cash and cash equivalents
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Operating lease right-of-use asset
Intangible assets
Goodwill
Other assets
Total assets
Liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)
Current liabilities:
Accounts payable
Accrued expenses and other current liabilities
Notes payable with related parties
Due to related parties
Operating lease liabilities, current
Contingent consideration, current
Total current liabilities
Deferred tax liabilities
Operating lease liabilities, noncurrent
Contingent consideration, noncurrent
Total liabilities
Redeemable convertible preferred stock
Series Seed Preferred Stock
Series A Redeemable Convertible Preferred Stock
Series A-1 Redeemable Convertible Preferred Stock
Series B Redeemable Convertible Preferred Stock
Total redeemable convertible preferred stock
Stockholders' equity (deficit):
Common stock, par value $0.00001 per share: 800,000,000 and 72,348,953 shares authorized as of September 30, 2025 and December 31, 2024, respectively; 105,152,658 and 15,368,385 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively.
Additional paid-in capital
Accumulated other comprehensive income (loss)
Accumulated deficit
Total stockholders' equity (deficit)
Total liabilities, redeemable convertible preferred stock and stockholders' equity (deficit)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support